ANAHEIM, CALIF. - Medical injection molder and extruder Haemotronic SpA plans to install at least 10 molding machines in a Class 100,000 clean room being built at its headquarters facility in Mirandola, Italy. The project is expected to be completed during 1996's first quarter.
The company operates in the United States through Haemotronic Inc., a marketing and distribution arm based in Fairfield, N.J., Charles A. Goudy, a manager in the U.S. firm's OEM Division, said at the Medical Design & Manufacturing show in Anaheim.
The integrity of the clean-room operation is assured by keeping parts in a controlled atmosphere through the use of an interlock, Goudy said. He de-clined to reveal the square footage of the addition.
The privately held Haemo-tronic reported revenues of more than $20 million, and it has one manufacturing plant in Mirandola with more than 50 injection molding machines that have clamping forces of 95-250 tons.
The firm processes several resin types, including PVC, polycarbonate, polypropylene, polyethylene and acrylics, he said.
The plant also has six extrusion lines, Goudy said. Four lines extrude tubing with diameters of 0.16-0.25 inches, and two lines produce bags of up to 270 millimeters in diameter for injectable solutions. Goudy said the OEM Division sells to several major medical suppliers.
The new, clean-room interlock feature comes in addition to the company's 20 percent increase in research and development expenses in 1995-96 and its work to expand distribution capabilities by boosting its U.S. warehouse space by 40 percent, Goudy said.
The improvements are intended to expand the company's role as a ``premium OEM supplier in oncology, anaesthesiology and cardiology,'' Goudy said.